Telmisartan may also reduce new onset of LVH ( nonhypertensive patients P < @ ; hypertensive patients P < @ ) in both subgroups , and new onset of microalbuminuria and macroalbuminuria in hypertensive patients ( P < @ and P < @ , respectively ) .